Patents by Inventor Philip W. Kantoff

Philip W. Kantoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for predicting likelihood of responding to treatment
    Patent number: 11214837
    Abstract: The disclosure provides materials and methods related to using biomarkers for prediction of duration of response to prostate cancer treatment and for treating prostate cancer.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: January 4, 2022
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Philip W. Kantoff, Ming Yang, Gwo-Shu Mary Lee, Tong Sun, Wanling Xie
  • METHODS FOR PREDICTING LIKELIHOOD OF RESPONDING TO TREATMENT
    Publication number: 20190284634
    Abstract: The disclosure provides materials and methods related to using biomarkers for prediction of duration of response to prostate cancer treatment and for treating prostate cancer.
    Type: Application
    Filed: March 12, 2019
    Publication date: September 19, 2019
    Inventors: Philip W. Kantoff, Ming Yang, Gwo-Shu Mary Lee, Tong Sun, Wanling Xie
  • Methods for predicting likelihood of responding to treatment
    Patent number: 10273544
    Abstract: The disclosure provides materials and methods related to using biomarkers for prediction of duration of response to prostate cancer treatment and for treating prostate cancer.
    Type: Grant
    Filed: February 11, 2011
    Date of Patent: April 30, 2019
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Philip W. Kantoff, Ming Yang, Gwo-Shu Mary Lee, Tong Sun, Wanling Xie
  • METHODS FOR PREDICTING LIKELIHOOD OF RESPONDING TO TREATMENT
    Publication number: 20130095481
    Abstract: The disclosure provides materials and methods related to using biomarkers for prediction of duration of response to prostate cancer treatment and for treating prostate cancer.
    Type: Application
    Filed: February 11, 2011
    Publication date: April 18, 2013
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Philip W. Kantoff, Ming Yang, Gwo-Shu Mary Lee, Tong Sun, Wanling Xie
  • Predicting And Treating Prostate Cancer
    Publication number: 20120121618
    Abstract: The disclosure features methods and compositions for determining whether a male subject has, or is at an increased risk of developing, an aggressive form of prostate cancer. The disclosure also features methods for adjusting a treatment regimen (e.g., discontinuing a therapy comprising an antioxidant) or administering a therapy that does not contain an antioxidant for a male subject in view of one or both of an MnSOD2 genotype status and an elevated level of an antioxidant in a biological sample obtained from the male subject. Also featured are methods for reducing superoxide levels in a subject based on one or both of an MnSOD2 genotype status and an elevated level of an antioxidant in a biological sample obtained from the male subject.
    Type: Application
    Filed: February 12, 2010
    Publication date: May 17, 2012
    Inventors: Philip W. Kantoff, William K. Oh, June M. Chan, Wanling Xie, Miyako Abe, Lorelei A. Mucci
  • Method for predicting the risk of prostate cancer morbidity and mortality
    Patent number: 6300060
    Abstract: There is described a method for prognosis of prostate cancer in a male comprising: (a) determining the length of the CAG trinucleotide repeat of exon 1 of the androgenic receptor gene and/or the length of the TA dinucleotide repeat of the 5 alpha reductase Type II gene or its complement obtained from DNA of the male and (b) correlating the length of the repeat with the aggressiveness and mortality risk of the cancer in the male.
    Type: Grant
    Filed: May 16, 1996
    Date of Patent: October 9, 2001
    Assignees: Dana-Farber Cancer Institute, Inc., The Brigham and Women's Hospital, Inc.
    Inventors: Philip W. Kantoff, Myles Brown, Edward Giovannucci